Future prospects for inflammatory bowel disease
Predictive medicine: Using biomarkers to predict the success of therapy
Symposium 213, Milan (Italy), October 2018Milan
. Over the past few years, the therapeutic possibilities for inflammatory bowel diseases (IBD) have expanded considerably. This trend looks set to continue in the future. For this reason, the question of when which patient should receive which therapy is becoming even more significant. More...
Bile acid research: Basis for new therapeutic concepts
UDCA and norUDCA: two bile acids with a future, not just in hepatology
Symposium 211, Dublin (Ireland), July 2018
The interest was enormous: The XXV Bile Acid Meeting of the Falk Foundation e.V. in Dublin was attended by 520 scientists from about 40 countries – more than ever before. This underlines the increasing importance of bile acid research, not only for basic researchers, but also for clinical research. More...
Inflammatory bowel diseases
A change in perspective is pending with regard to diagnostics and therapy
Symposium 210, Lisbon (Portugal), April 2018
. “Big data” is also currently making its arrival with regard to inflammatory bowel diseases (IBD). For instance, there is an outright flood of data regarding factors which determine pathophysiology – from genome via the exposome and immunome to microbiome. More...
On the road to personalized nutritional therapy
Workshop, Hamburg (Germany), January 2018